Clinical trial
Prophylactic Desmopressin and Bleeding Outcomes After Native Kidney Biopsy in Patients With Severe Renal Impairment: A Prospective Sequential Cohort Study
NCT07840313 is registered in ClinicalTrials.gov with Sindh Institute of Urology and Transplantation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prophylactic Desmopressin and Bleeding Outcomes After Native Kidney Biopsy in Patients With Severe Renal Impairment: A Prospective Sequential Cohort Study
- Lead sponsor
- Sindh Institute of Urology and Transplantation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 1, 2017
- Completion date
- November 30, 2017
- Enrollment
- 250 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
severe renal impairment